Article
Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma
1 Dec 2015
Abstract excerpt
BACKGROUND: In order to predict long-term prognosis and define individual treatment modalities for patients with oral squamous cell carcinoma (OSCC), more reliable tumor biomarkers are needed during the pretreatment workup period. The present study aimed to identify more reliable immunohistochemical tumor prognostic markers in the pretreatment biopsy specimens of patients with OSCC. METHODS: We selected 57...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
